SciDev.Net
Science and Development Network
News, views and information about science, technology and the developing world
Search Archive
News archive results 1-20 of 79 in Health and Access to medicine
Swine flu science update: 24 November 2009
A roundup of articles about vaccines for poor countries, the common cold protecting against swine flu, vaccine strength and more.
NEWS | 24 November 2009 | EN
Swine flu science update: 16 November 2009
A round up of articles about delays in shipping donated vaccine, how to define a pandemic, new antivirals, and more.
Scientists 'must ensure key research reaches the poor'
Scientists must lobby policymakers and politicians to ensure that vital research on maternal and child health saves lives, say the authors of a report.
NEWS | 11 November 2009 | EN
Addressing poverty to reduce chronic diseases
The Pan American Health Organization has proposed to reduce poverty in a bid to tackle chronic diseases.
NEWS | 9 November 2009 | ES
Malaria impasse 'could be overcome with brain scans'
MRI scans could transform scientists' understanding of cerebral malaria but the technology is barely used, say researchers
Tapeworm link with epilepsy 'far higher' than thought
Pork tapeworm is responsible for almost a third of epileptic fits, researchers say.
NEWS | 2 November 2009 | EN
Surge in vaccine research fails to reach neediest
Millions of children are missing out on the fruits of an explosion in vaccine development because they are too difficult to reach.
NEWS | 22 October 2009 | EN
Global vaccination effort could wipe out HPV
A Nobel Prize winner has called for global rollout of vaccines that protect against cervical cancer — a big killer in the developing world.
Swine flu science update: 5 October 2009
A round-up of articles about the unexpected success of single-dose vaccines, vaccine distribution to developing countries, and more.
Commercial trade raises drug prices in Guatemala
In Guatemala the US commercial trade rules on intellectual property have reduced access to some generic drugs, says a study.
NEWS | 2 September 2009 | ES
Software allows public to map medicine shortages
National maps revealing drug shortages have been created by getting locals to text their discoveries to an online mapping system.
NEWS | 1 September 2009 | EN
Brazil has paved way for tackling HIV/AIDS, says study
Brazil's strategy for tackling HIV/AIDS — including the production of generic drugs — is an example to the developing world, say researchers.
Swine flu science update: 18 June 2009
A round-up of articles about using alternatives to antivirals to fight swine flu, making vaccine available to poor nations and mapping risk.
Health agencies join forces to fight chronic diseases
The huge burden of chronic diseases in developing countries could be cut by an alliance of agencies teaming up for research.
New sickle cell treatment ready for testing
An experimental drug promises to ease the pain of sickle cell anaemia — but first it must be made affordable.
WHO 'will ensure poor receive swine flu vaccine'
The WHO says it is investigating ways of ensuring that developing countries get access to future vaccines against swine flu.
Poor may lose out in swine flu vaccine production
Vaccine production is likely to be confined to a handful of developed countries whose order books will be full, say critics.
Brazil: ‘high acceptance level’ of vaccine against HPV
A survey in Brazil shows that most of the physicians and medical students accept the vaccination against human papilloma virus for girls.
NEWS | 29 April 2009 | ES
Rates of HIV-positive newborns reduced in Haiti
A pilot programme aiming to reduce mother-to-child transmission of HIV has reduced infection in babies from 27 to nine per cent.
NEWS | 9 April 2009 | ES
Glaxo patent rethink sparks debate
GlaxoSmithKline's change in neglected disease policy — offering patents, research facilities and low drug prices — has not pleased everyone.
Information Services
Missed the Global Health Forum 2009?
Our blog, by SciDev.Net columnist Priya Shetty, will fill you in, as will our interview with the Global Forum's Gill Samuels
